substance p has been researched along with ketamine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Ivanova, LI; Patyshakuliev, AP; Rogacheva, SK; Zilov, VG | 1 |
| Daló, NL; Larson, AA | 1 |
| Hirose, Y; Kosaka, F; Mori, A; Ogawa, N; Ono, T; Pongdhana, K | 1 |
| Brunson, DB; Buckner, CK; Laravuso, RB; Leblanc, PH; Will, JA | 1 |
| Beal, MF; Ferrante, RJ; Kowall, NW; Martin, JB; Swartz, KJ | 1 |
| Song, XJ; Zhao, ZQ | 1 |
| Cuello, AC; Henry, JL; Julien, JP; McLeod, AL; Ribeiro-Da-Silva, A; Ritchie, J | 1 |
| Fujimoto, T; Hanaoka, K; Nishiyama, T | 1 |
| Antonelli, A; Barone, G; Chiaretti, A; Genovese, O; Lazzareschi, I; Maurizi, P; Paiano, S; Riccardi, R; Ruggiero, A; Sammartino, M | 1 |
| Almeida, MPA; Bakhle, YS; Frade, TIC; Francischi, JN; Queiroz, BFG | 1 |
| Inada, E; Kumakura, S; Murakami, T; Nagaoka, I; Someya, A; Yamaguchi, K | 1 |
| Chuang, YC; Lee, WC; Su, CH; Tain, YL; Tsai, CN; Yu, CC | 1 |
| Doi, M; Imado, E; Irifune, M; Kanematsu, T; Kochi, T; Morioka, N; Mukai, A; Nakamura, Y; Nakata, Y; Onizuka, C; Oue, K; Sakai, N; Shimizu, Y; Yoshida, M | 1 |
13 other study(ies) available for substance p and ketamine
| Article | Year |
|---|---|
[Beta-adrenoblockers in the reorganizing of the food center of the hypothalamus under the influence of substance P].
Topics: Adrenergic beta-Antagonists; Animals; Droperidol; Drug Interactions; Feeding Behavior; Hypothalamic Area, Lateral; Ketamine; Male; Propranolol; Rabbits; Reaction Time; Substance P | 1992 |
Effects of urethane and ketamine on substance P- and excitatory amino acid-induced behavior in mice.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Behavior, Animal; Injections, Spinal; Isomerism; Kainic Acid; Ketamine; Male; Mice; N-Methylaspartate; Quisqualic Acid; Substance P; Urethane | 1990 |
Effects of ketamine on the cholecystokinin, somatostatin, substance P, and thyrotropin releasing hormone in discrete regions of rat brain.
Topics: Animals; Brain; Cholecystokinin; Corpus Striatum; Frontal Lobe; Hippocampus; Ketamine; Male; Mesencephalon; Rats; Rats, Inbred Strains; Rhombencephalon; Somatostatin; Substance P; Thalamus; Thyrotropin-Releasing Hormone | 1987 |
Differential effect of ketamine on cholinergic- and noncholinergic-induced contractions of isolated guinea-pig bronchi.
Topics: Animals; Bronchi; Carbachol; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Ketamine; Muscle Contraction; Muscle, Smooth; Parasympathetic Nervous System; Reserpine; Substance P; Sympathetic Nervous System | 1987 |
Systemic approaches to modifying quinolinic acid striatal lesions in rats.
Topics: 2-Amino-5-phosphonovalerate; Allopurinol; Amino Acids; Animals; Antioxidants; Baclofen; Corpus Striatum; Dibenzocycloheptenes; Disease Models, Animal; Dizocilpine Maleate; Huntington Disease; Ketamine; Male; Neuropeptide Y; Nimodipine; Peptides; Pyridines; Quinolinic Acid; Quinolinic Acids; Rats; Rats, Inbred Strains; Substance P; Taurine; Valine | 1988 |
Interaction between substance P and excitatory amino acid receptors in modulation of nociceptive responses of cat spinal dorsal horn neurons.
Topics: 2-Amino-5-phosphonovalerate; Animals; Cats; Electric Stimulation; Homocysteine; Ketamine; Kynurenic Acid; Muscles; Neurokinin-1 Receptor Antagonists; Neurons; Nociceptors; Quinoxalines; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurokinin-1; Spinal Cord; Substance P; Sural Nerve | 1994 |
Transgenic mice over-expressing substance P exhibit allodynia and hyperalgesia which are reversed by substance P and N-methyl-D-aspartate receptor antagonists.
Topics: Analgesics; Animals; Biphenyl Compounds; Excitatory Amino Acid Antagonists; Gene Expression Regulation; Hot Temperature; Hyperalgesia; Ketamine; Male; Mice; Mice, Transgenic; Myelin Basic Protein; Neurokinin-1 Receptor Antagonists; Nociceptors; Promoter Regions, Genetic; Reaction Time; Receptors, N-Methyl-D-Aspartate; Recombinant Fusion Proteins; Spinal Cord; Stress, Mechanical; Substance P | 1999 |
Inhibitory effects of intravenous anesthetics on mast cell function.
Topics: Anesthetics, Intravenous; Animals; Chemotaxis; Dogs; Dose-Response Relationship, Drug; Ketamine; Mast Cells; Midazolam; Propofol; Substance P; Thiopental | 2005 |
Propofol/alfentanil and propofol/ketamine procedural sedation in children with acute lymphoblastic leukaemia: safety, efficacy and their correlation with pain neuromediator expression.
Topics: Adolescent; Alfentanil; Anxiety; Child; Child, Preschool; Conscious Sedation; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Ketamine; Male; Nerve Growth Factor; Pain; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Propofol; Prospective Studies; Spinal Puncture; Substance P; Treatment Outcome | 2010 |
Ketamine-xylazine anaesthesia and orofacial administration of substance P: A lethal combination in rats.
Topics: Anesthesia; Animals; Edema; Isoflurane; Ketamine; Male; Models, Animal; Piperidines; Quinuclidines; Rats, Wistar; Substance P; Xylazine | 2017 |
Ketamine suppresses the substance P-induced production of IL-6 and IL-8 by human U373MG glioblastoma/astrocytoma cells.
Topics: Astrocytoma; Cell Line, Tumor; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Glioblastoma; Humans; Interleukin-6; Interleukin-8; Ketamine; MAP Kinase Signaling System; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Substance P | 2017 |
Ba-Wei-Die-Huang-Wan (Hachimi-jio-gan) can ameliorate ketamine-induced cystitis by modulating neuroreceptors, inflammatory mediators, and fibrogenesis in a rat model.
Topics: Animals; Collagen; Cyclooxygenase 2; Cystitis; Drugs, Chinese Herbal; Female; Fibronectins; Functional Neuroimaging; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-6; Ketamine; Magnetic Resonance Imaging; NF-kappa B; Periaqueductal Gray; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Sensory Receptor Cells; Substance P; Transforming Growth Factor beta1; TRPV Cation Channels; Tumor Necrosis Factor-alpha; Urinary Bladder; Urinary Bladder, Overactive; Urothelium | 2019 |
Pentobarbital may protect against neurogenic inflammation after surgery via inhibition of substance P release from peripheral nerves of rats.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Calcium Channels; Capsaicin; Cells, Cultured; Ganglia, Spinal; Ketamine; Male; Neurogenic Inflammation; Pentobarbital; Peripheral Nerves; Rats; Rats, Wistar; Sensory System Agents; Substance P; TRPV Cation Channels | 2022 |